Mantle Cell Lymphoma
From the Journals
CAR-T outcomes similar among diverse cancer patients
Black, Hispanic, White, and Asian cancer patients showed comparable responses to CAR-T therapy, a study indicates.
Latest News
New trials in lymphoma and MM: Could your patient benefit?
Late-phase clinical trials are opening up, with a chance to enroll one or more of your patients.
Conference Coverage
ZUMA-2, TRANSCEND data pique interest in earlier CAR T for R/R MCL
From the Journals
Don’t delay: Cancer patients need both doses of COVID vaccine
For patients with cancer, immune response to the first dose of the Pfizer COVID-19 vaccine is reduced, and there is a need for a booster dose at...
From the Journals
New BTK inhibitor shows promise in previously failed B-cell malignancies
Pirtobrutinib (formerly known as LOXO-305) is an oral-dose, highly selective, reversible BTK inhibitor.
Roundtable Discussion
Mantle Cell Lymphoma Roundtable Discussion
Management of refractory mantle cell lymphoma
Conference Coverage
Survey quantifies COVID-19’s impact on oncology
Oncologists detail how COVID-19 has impacted care, caregivers, continuing medical education, and clinical trials.
From the Journals
Hepatitis screening now for all patients with cancer on therapy
All patients with cancer who are candidates for systemic therapy should be screened for hepatitis B, says the American Society of Clinical...
News
FDA okays new CAR T therapy, first for mantle cell lymphoma
Roundtables
Mantle Cell Lymphoma 2020 Roundtable Discussion
From the Journals
COVID-19: Experts hasten to head off mental health crisis
Across the two surveys, respondents’ primary concern was anxiety, which was cited in 750 responses.